Morgan Creek Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIGR
Figure Technology Solutions
FIGR
|
+$18.9M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$226K |
| 3 |
Acadia Pharmaceuticals
ACAD
|
+$207K |
| 4 |
PTC Therapeutics
PTCT
|
+$199K |
| 5 |
Biohaven
BHVN
|
+$196K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GEMI
Gemini Space Station
GEMI
|
+$9.83M |
| 2 |
Unity
U
|
+$205K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 93.54% |
| 2 | Technology | 4.25% |
| 3 | Healthcare | 1.09% |
| 4 | Real Estate | 0.86% |
| 5 | Energy | 0.26% |
Similar funds
Morgan Creek Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Creek Capital Management held 16 positions worth $148M, down 2% from $151M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Morgan Creek Capital Management deployed $10.4M of net new capital in Q2 2026, opening 7 new positions and adding to 2 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 332 shares worth $207K.
By sector, the portfolio is most concentrated in Financials at 94% of assets, down from 95% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gemini Space Station, an estimated $9.83M trimmed.
- Morgan Creek Capital Management's largest Q2 2026 buy was Regeneron Pharmaceuticals: 332 shares worth $207K.
- Morgan Creek Capital Management added most to Figure Technology Solutions in Q2 2026, an estimated $18.9M increase.
- Morgan Creek Capital Management's biggest Q2 2026 reduction was Gemini Space Station, cutting an estimated $9.83M.
- Morgan Creek Capital Management fully exited Unity in Q2 2026, selling an estimated $205K.
- Morgan Creek Capital Management's ten largest holdings make up 99% of its $148M portfolio in Q2 2026.
- Morgan Creek Capital Management opened 7 new positions and closed 1 in Q2 2026.
- Morgan Creek Capital Management's portfolio value fell 2% quarter-over-quarter to $148M.
Based on Morgan Creek Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.